We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Technique for Detecting Cancer Could Replace Biopsies

By MedImaging International staff writers
Posted on 06 Apr 2015
Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).
Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).
A study suggests Magnetic Resonance Imaging (MRI) could be used for the noninvasive detection of cancer cells to complement or replace biopsies, without the need for injection of contrast dyes.

Researchers at Johns Hopkins School of Medicine (Baltimore, MD, USA) tested a technique that detects sugar molecules shed by the outer membranes of cancerous cells, so far only on lab-grown cells and mice.

The results of the study were published on online, in the journal Nature Communications on March 27, 2015.

Xiaolei Song, PhD, the lead author on the study, said, “This is the first time a property integral to cancer cells, rather than an injected dye, has been used to detect those cells. The advantage of detecting a molecule already inside the body is that we can potentially image the entire tumor. This often isn’t possible with injected dyes because they only reach part of the tumor. Plus, the dyes are expensive.

The team will next try to distinguish additional types of cancerous tumors from benign masses in live mice. If they succeed it could lead to earlier detection of cancer, new methods to monitor response to chemotherapy, and new ways to guide biopsies that may eventually make some biopsies unnecessary.

Related Links:

Johns Hopkins School of Medicine


X-ray Diagnostic System
FDX Visionary-A
MRI System
nanoScan MRI 3T/7T
Digital Radiographic System
OMNERA 300M
Ultrasound Table
Women’s Ultrasound EA Table

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.